K Number
K120438
Device Name
FLASH (DIFFERENT MATERIALS)
Date Cleared
2012-05-02

(79 days)

Product Code
Regulation Number
872.3660
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Flash VPS Impression Materials are indicated to be used for all precision impressions (of e.g .: crown, bridge, inlay and onlay preparations).
Device Description
Flash materials are classified as impression materials (21 C.F.R. § 872.3660) because they are devices intended to reproduce the structure of a patient's teeth. Flash will be available as wash and tray materials. The wash materials will be available in one viscosity (light-bodied), each of them in a regular set and a super-quick set version. The tray materials will be available in two different viscosities (putty and heavy-bodied) in a regular set and a super-quick set version. As the predicate devices, Flash materials are two component (base paste/catalyst) vinyl polysiloxane impression materials designed either to be used in 3M Deutschland GmbH's mixing, dosing and dispensing device, Garant™, or to automatically be mixed and dispensed in the Pentamix™ device of 3M Deutschland GmbH.
More Information

Not Found

No
The document describes a traditional dental impression material and its dispensing system, with no mention of AI or ML.

No
The device is an impression material meant to reproduce the structure of a patient's teeth, not to treat a disease or condition.

No

The device is an impression material used to reproduce the structure of teeth, which is a step in various dental procedures (e.g., making crowns, bridges). It does not provide information about the presence, absence, or state of a disease or condition.

No

The device is described as "impression materials" which are physical substances used to reproduce the structure of teeth, not software. It also mentions being used with physical mixing and dispensing devices.

Based on the provided text, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to "reproduce the structure of a patient's teeth" for "all precision impressions." This is a physical process for creating a mold of teeth, not a test performed on a sample taken from the body to diagnose a condition.
  • Device Description: The description clearly states it's an "impression material" used to "reproduce the structure of a patient's teeth." This aligns with a dental impression material, not an IVD.
  • Lack of IVD Characteristics: The description does not mention analyzing biological samples (blood, urine, tissue, etc.), detecting markers of disease, or providing diagnostic information.

IVDs are devices used to perform tests on samples from the human body to provide information for the diagnosis, monitoring, or treatment of diseases or conditions. This device does not fit that description.

N/A

Intended Use / Indications for Use

Flash VPS Impression Materials are indicated to be used for all precision impressions (of e.g.: crown, bridge, inlay and onlay preparations).

Product codes

ELW

Device Description

Flash materials are classified as impression materials (21 C.F.R. § 872.3660) because they are devices intended to reproduce the structure of a patient's teeth.

Flash will be available as wash and tray materials. The wash materials will be available in one viscosity (light-bodied), each of them in a regular set and a super-quick set version. The tray materials will be available in two different viscosities (putty and heavy-bodied) in a regular set and a super-quick set version.

As the predicate devices, Flash materials are two component (base paste/catalyst) vinyl polysiloxane impression materials designed either to be used in 3M Deutschland GmbH's mixing, dosing and dispensing device, Garant™, or to automatically be mixed and dispensed in the Pentamix™ device of 3M Deutschland GmbH.

In this 510(k) premarket notification Flash has been compared to the predicate devices with regard to indications for use, physical and mechanical properties, and chemical composition. The comparison for indications for use, performance data, and chemistry shows that Flash is substantially equivalent to the predicate devices.

Biocompatibility testing was carried out. Biocompatibility assessments were developed for Flash using standard risk assessment techniques and consideration of FDA & internationally recognized guidelines. The conclusion of the assessments is that Flash materials are biocompatible for its intended use.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Comparison for indications for use, performance data, and chemistry shows that Flash is substantially equivalent to the predicate devices.
Biocompatibility testing was carried out. Biocompatibility assessments were developed for Flash using standard risk assessment techniques and consideration of FDA & internationally recognized guidelines. The conclusion of the assessments is that Flash materials are biocompatible for its intended use.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K051797, K000591, K963766

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 872.3660 Impression material.

(a)
Identification. Impression material is a device composed of materials such as alginate or polysulfide intended to be placed on a preformed impression tray and used to reproduce the structure of a patient's teeth and gums. The device is intended to provide models for study and for production of restorative prosthetic devices, such as gold inlays and dentures.(b)
Classification. Class II (Special Controls).

0

1/120438

MAY - 2 2012

510(k) SUMMARY OF SAFETY AND EFFECTIVENESS

Submitter

Company:3M Deutschland GmbH
Street:ESPE Platz
ZIP-Code, City:D-82229 Seefeld
Federal State:Bavaria
Country:Germany
Establishment Registration Number9611385
Official Correspondent:Dr. Desi W. Soegiarto,
Regulatory Affairs Specialist
Phone:+49-8152-700 1169
Fax:+49-8152-700 1869
E-mail:desi.soegiarto@mmm.com
Date:February 10. 2012

Name of Device

Proprietary Name: ............................................................................................................................................................

Flash Penta™ HB SQ Flash Penta™ HB Q Flash Heavy Body SQ Flash Heavy Body Q Flash Regular Body SQ Flash Regular Body Q Flash Light Body SQ Flash Light Body Q Flash Ultra-Light Body SQ Flash Penta™ Putty

1

Classification Name:Impression material
Common Name:Dental impression material

Predicate Devices

Future Wash/YPS by 3M Deutschland GmbH, Germany ......... K051797 Dimension Penta H by 3M Deutschland GmbH, Germany ....... K000591 3M ProPlus System by 3M ESPE Dental Products, U.S.A. ....... K963766

Description for the Premarket Notification

Flash materials are classified as impression materials (21 C.F.R. § 872.3660) because they are devices intended to reproduce the structure of a patient's teeth.

Flash will be available as wash and tray materials. The wash materials will be available in one viscosity (light-bodied), each of them in a regular set and a super-quick set version. The tray materials will be available in two different viscosities (putty and heavy-bodied) in a regular set and a super-quick set version.

As the predicate devices, Flash materials are two component (base paste/catalyst) vinyl polysiloxane impression materials designed either to be used in 3M Deutschland GmbH's mixing, dosing and dispensing device, Garant™, or to automatically be mixed and dispensed in the Pentamix™ device of 3M Deutschland GmbH.

In this 510(k) premarket notification Flash has been compared to the predicate devices with regard to indications for use, physical and mechanical properties, and chemical composition. The comparison for indications for use, performance data, and chemistry shows that Flash is substantially equivalent to the predicate devices.

Biocompatibility testing was carried out. Biocompatibility assessments were developed for Flash using standard risk assessment techniques and consideration of FDA & internationally recognized guidelines. The conclusion of the assessments is that Flash materials are biocompatible for its intended use.

2

In summary, it can be concluded that Flash is as substantially equivalent in safety and effectiveness as the predicate devices Future Wash/YPS by 3M Deutschland GmbH, Germany (K051797), Dimension Penta H by 3M Deutschland GmbH, Germany (K000591), and 3M ProPlus System by 3M ESPE Dental Products, U.S.A. (K963766).

Indications for Use:

Flash VPS Impression Materials are indicated to be used for all precision impressions (of e.g .: crown, bridge, inlay and onlay preparations).

3

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized eagle with three stripes forming its body and wing. The eagle is facing right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the eagle.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Dr. Desi W. Soegiarto Regulatory Affairs Specialist 3M Deutschland GmbH ESPE Platz D-8229 Seefeld GERMANY

Re: K120438

Trade/Device Name: Flash Regulation Number: 21 CFR 872.3660 Regulation Name: Impression Material Regulatory Class: II Product Code: ELW Dated: February 10, 2012 Received: February 13, 2012

Dear Dr. Soegiarto:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

MAY - 2 2012

4

Page 2 - Dr. Soegiarto

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours,

Clintons

Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation . Center for Devices and Radiological Health

5

Indications for Use